Scientists from the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) have successfully tested a new form of cellular immunotherapy against brain tumors in mice for the first time.
Sep 26, 2023
0
55
Accessing the brain for neurosurgery involves drilling and cutting that can cause deep-brain anatomy to shift or become distorted. This can create discrepancies between pre-operative imaging and the actual state of the brain ...
Aug 31, 2023
0
1
A diagnosis of a brain tumor can be frightening. Of the more than 100 types of brain tumors, meningioma and glioblastoma are two of the most common.
Aug 14, 2023
0
1
Researchers from The University of Texas MD Anderson Cancer Center found the KRAS G12C inhibitor adagrasib showed promising activity suppressing cancer growth not only within the lungs but also in brain metastases for patients ...
Jun 16, 2023
0
28
Cancer that spreads to the brain from another part of the body such as lung or breast is called a metastatic brain tumor. As metastatic brain tumors grow, they can cause symptoms such as headaches, seizures and weakness or ...
Jun 8, 2023
0
4
In an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening. The finding suggests ...
Jun 5, 2023
0
70
Cancer is a sneaky disease. Find one method of treating it successfully, and it finds another way to survive.
May 22, 2023
0
34
The first in-human-study of a new immunotherapy that blocks a natural enzyme tumors commandeer for their protection was well tolerated by children with relapsed brain tumors and enabled many to have unexpected months of a ...
Apr 25, 2023
0
9
St. Jude Children's Research Hospital is reporting phase 2 clinical trial results treating the brain tumor craniopharyngioma with proton therapy. The researchers found a similar survival rate between more targeted proton ...
Apr 19, 2023
0
46
It's a good news, bad news story. Patients whose brain tumors have a mutated enzyme called IDH1 typically live longer than those without the mutation. But even as these tumors are initially less aggressive, they always come ...
Jan 24, 2023
0
19
